– UK, Twyford – Interserve (LSE:IRV), the international support services and construction group, is pleased to announce that Gareth Edwards will join the Board from 1 February 2017 as a non-executive director.
Gareth has extensive experience as an advisor to Boards and CEOs in a range of public (predominantly FTSE 250), private and entrepreneurial companies on their strategy and wider business issues. He also has considerable international experience, particularly in the Middle East.
Gareth is a director of Positive Healthcare plc and a partner at the law firm Pinsent Masons LLP, specialising in corporate finance work. During the last few years Gareth has spent much of his time expanding the Pinsent Masons offices in continental Europe and facilitating its business development between Asian, Middle Eastern and European offices.
Glyn Barker, Chairman of Interserve, said: “I am delighted to welcome Gareth to Interserve. His commercial background and his extensive international experience, particularly in the Middle East, will bring great value to the Board.”
Interserve is one of the world’s foremost support services and construction companies. Our vision is to redefine the future for people and places. Everything we do is shaped by our core values. We are a successful, growing, international business: a leader in innovative and sustainable outcomes for our clients and a great place to work for our people. We offer advice, design, construction, equipment, facilities management and frontline public services. We are headquartered in the UK and FTSE-listed. We have gross revenues of £3.6 billion and a workforce of circa 80,000 people worldwide.
For more information : http://www.interserve.com
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
Comments are closed.